00:16 , Apr 6, 2019 |  BioCentury  |  Finance

Room to rally in 2Q

Strong small and mid-cap performance coupled with robust M&A has brought the sector back from 4Q18 correction territory, and chances are good for the momentum to continue given the ample capital ready to be recycled...
18:52 , Mar 29, 2019 |  BC Week In Review  |  Company News

Guardant Health to acquire fellow cancer diagnostic company Bellwether Bio

Liquid biopsy company Guardant Health said it will advance its early detection product pipeline by acquiring Bellwether Bio for an undisclosed sum. Bellwether Bio Inc. (Seattle, Wash.) is developing cancer diagnostics based on the epigenomics...